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Summary 
In the present report, we have investigated the in vitro differentiation of surface(s) slgD + and 
slgD- human B cells into Ig-secreting calls in response to various stimuli, slgD + B cells homo- 
geneously expressed some of the antigens identifying mantle zone B cells, but lacked expression 
of germinal center markers,  thus confirming that the B cell populations positively selected on 
the basis of slgD expression were highly enriched for naive B lymphocytes. Conversely, slgD- 
B cells expressed some of the antigens spedfically  associated with germinal center B cells. T 
cell-independent differentiation of slgD + and sIgD- B cells could be achieved by simultaneous 
crosslinking of sIgs and CD40 in the presence of a mouse Ltk- cell line stably expressing human 
CDw32/Fc'yPdI (CDw32 L cells). In this experimental system, sIgD + B cells were exclusively 
proned for IgM synthesis, whereas sIgD- B ceils produced IgG, IgM, and IgA. Both the human 
and viral forms of interleukin 10 (ILd0) strongly increased the Ig secretion by sIgD + and slgD- 
B cells simultaneously activated through slgs and CD40. IgM and IgG constituted the predominant 
Ig isotype produced by slgD + and slgD-  B cells, respectively, in response to IL-10. slgD + B 
cells could be induced for IgA synthesis upon co-culturing with transforming growth factor 
(TGF-~) and II.-10, in the presence of an anti-CD40 monodonal antibody presented by the 
CDw32 L cells. In contrast, TGF-~ suppressed the IL-10-mediated IgG, IgM, and IgA secretions 
by slgD-  B cells, slgD + B cells could not be induced for IgA synthesis by TGF-~ and Ibl0 
after crosslinking of their slgs, suggesting that ligation of CD40 was one of the obligatory signals 
required for commitment of naive B cells to IgA secretion. Limiting dilution experiments indicated 
that the IgA-potentiating effect of TGF-B was due to its capacity to increase the frequency of 
IgA-producing cells, most likely as a consequence of class switching. Taken together, our data 
strongly suggest that TGF-B is involved in the regulation of IgA isotype selection in humans. 
T 
he pattern of Ig classes secreted by B cells in response 
to antigenic stimulation depends upon several  factors such 
as the structure of the antigen and the anatomic site in which 
the immune response takes place. The production of high 
affinity antibodies using downstream heavy chain genes, in 
the course of a secondary immune response, results from a 
maturation process initiated by the antigen itself, which occurs 
within the germinal centers of secondary follicles (1, 2). As 
recently demonstrated in the murine system (3, 4), the mo- 
lecular mechanism of class switching involves the rearrange- 
ment of the genes located on the heavy chain locus and the 
subsequent deletion of the C. genes intervening between a 
variable region exon and the C. gene to be expressed. Evi- 
dence supports the notion that this process is directed and 
regulated by cytokines and other environmental signals de- 
livered to B cells through interactions with other cell types. 
In mice, Ib4 has been described to regulate the secretion of 
IgE and IgG1, whereas IFN-'g and TGF-~ have been associated 
with the induction of IgG2a and IgA synthesis, respectively 
(5, 6). In humans, it is now recognized that IL-4 is involved 
in IgE (7, 8) and IgG4 (9,  10) heavy chain switching, but 
to this date, the cytokine-mediated  regulation of IgG1, IgG2, 
IgG3, and IgA isotypes has not been elucidated. The relative 
lack of information on that matter in the human system may 
partly relate to differences in the experimental models used 
in mice and in humans. Indeed, murine studies have essen- 
tially relied on the use of LPS to initiate responsiveness of 
B cells to switch factors, whereas such a tool was not avail- 
able for human B cells until recently. Consequently, the study 
of the cytokine regulation of Ig isotype switching in humans 
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the activation systems, precluding the culture of B cells in 
limiting dilutions. In addition, the maturational state of the 
B cell populations studied in early experiments was poorly 
defined and did not  allow discrimination  between isotype 
switching  and maturation  of pre-committed precursors. 
However, two novel experimental systems in which highly 
efficient activation of human B ceils  could be achieved through 
triggering of non-Ig-related molecules have permitted us to 
overcome these technical difficulties.  The first one is based 
on the capacity of syngeneic or allogeneic activated T  cells 
to stimulate entry of B cells into cycle in a non-MHC-re- 
stricted fashion via direct cell-to-cell contact (11-14).  In the 
second one, polyclonal activation and sustained proliferation 
of human B cells is obtained by presentation of an anti-CD40 
mAb on irradiated mouse L cells stably expressing CDw32/ 
Fcq/glI (15). In both models, B calls can be induced for IgE 
synthesis after Ib4 stimulation (10, 16). The observation that 
Ib4 is not able to drive purified human B cells to differen- 
tiate into  IgE-secreting cells unless T  cells  (10),  EBV (17) 
or an anti-CD40 mAb (16, 18, 19) are provided, is consistent 
with the hypothesis that Ig isotype switching to IgE requires 
at least two signals,  one ddivered by IIr  the other medi- 
ated through CD40 or another B cell surface structure. There- 
fore, we explored the possibility that  the CD40 signaling 
pathway could also be involved in the control of IgG and 
IgA isotype selection. We based our experimental approach 
on the assumption that naive B cells positively sdected on 
the basis of sIgD expression and presumably depleted in post- 
switch B cells could constitute a suitable target for the detec- 
tion  of switch  events.  Isolated  sIgD +  and  sIgD-  B  cells 
were first compared for their capacity to secrete Ig in response 
to various B  cell stimulants.  In  the absence of exogenous 
factors, both B cell subsets were inducible for Ig secretion 
after costimulation with anti-Ig reagents and an anti-CD40 
mAb presented on CDw32 L cells, sIgD + B cells produced 
IgM exclusively, whereas slgD- B cells produced IgM, IgG, 
and IgA, with a predominance  of IgG. 
Both human Ibl0 and the EBV-encoded protein BCRF-11 
(or viral II.,10), presenting an extensive homology with the 
human molecule (20, 21), strongly enhanced the Ig response 
elicited in both B cell subsets by dual ligation  of sIgs and 
CD40. Furthermore, addition of TGF-B together with ILl0 
and crosslinked anti-CD40 antibodies resulted in a selective 
induction of IgA secretion from sIgD + B cells, but strongly 
suppressed the IL-10-mediated production of IgG, IgM, and 
IgA in the sIgD-  B cell subset.  The implications  of these 
findings on the possible role of CD40 and TGF-B in the con- 
trol of IgA isotype selection are discussed. 
Materiah  and Methods 
Reagents.  Insolubilized  anti-IgM  antibodies  were purchased 
from Bio-Rad Laboratories (Richmond,  CA) and were used at 5 
1 Abbreviations used in this paper: BCRF-1, Epstein-Barr virus BamHI C 
fragment, rightward reading flame 1; SAC, staphylococcus  aureus strain 
Cowan I. 
/~g/ml. Formalinized particles ofStaphflococcus aureus strain Cowan 
I (SAC) were purchased as Pansorbin from Calbiochem-Behring 
Corp. (San Diego, CA) and were used at the final concentration 
of 0.005% (vol/vol). FITC-conjugated streptavidin was purchased 
from Immunotech (Luminy, France). 
Antibodies.  The monoclonal and polyclonal antibodies used for 
phenotypic and functional studies were obtained from the following 
sources: PE-conjugated anti-CD2 (Leu 5), anti-CD3 (Leu 4), anti- 
CD20 (Leu 16) mAbs and unconjugated  anti-CD10,  anti-CD14 
(Leu M3), and anti-IgM mAbs (Becton Dickinson & Co., Moun- 
tain View, CA); anti-CD38 mAb (Ortho Pharmaceutical, Raritan, 
NJ); anti-CD2  and anti-CD3  mAbs used for negative selection of 
B cells with magnetic beads (Aster Laboratories, La Gaude, France); 
biotinylated,  goat anti-human IgD antibodies (Amersham Inter- 
national,  Amersham,  Bucks,  UK);  PE-conjugated  F(ab')2 frag- 
ments of sheep anti-mouse IgG and IgM antibodies used for in- 
direct irnmunofluorescence stainings (AMD; Eurobio, Paris, France). 
The anti-CD23/FceRII mAb 25 was prepared in the laboratory 
as previously described (22). The UCL-3D3 mAb specifically  recog- 
nizing mantle zone B cells (23) and the anti-CD44  mAb NKI-Pl 
(gp 90, Pgp-1, H-CAM) were kindly provided by Dr. P. Beverley 
(Courtauld Institute, London, UK) and Dr. S. T. Pals (Free Univer- 
sity, Amsterdam, The Netherlands),  respectively. The anti-CD40 
mAb 89 was produced in the laboratory  (24) and was used at a 
final concentration  of 0.5/~g/ml throughout the study. 
Factors.  Each  of the cytokines listed below was tested at var- 
ious doses chosen above and below the optimal concentration point 
determined  in spedfic bioassays as described in detail previously 
(16). For the sake of clarity, only the optimal concentration  value 
is mentioned here. Except where indicated, all cytokines were under 
the form of purified recombinant material. IL-lce (10  s U/mg), IL6 
(107 U/rag), and TNF-c~ (2  x  107 U/mg) were purchased from 
Genzyme Corp.  (Cambridge, MA). They were routinely used at 
100 U/ml,  5 ng/ml,  and 25 ng/ml,  respectively. Ib2 (3  x  106 
U/mg) and IFN-'Ir (107 U/rag) were purchased from Amgen Bio- 
logicals (Thousand Oaks, CA) and were routinely used at 20 U/ml 
and 500 U/ml. IL-3 (5  x  10  + U/mg) and IL-4 (107 U/mg) were 
kindly provided by Drs. S. Tindall and P. Trotta (Schering-Plough 
Research, Bloomfidd,  NJ). They were used at 10 ng/ml and 500 
U/ml, respectively. IbS, semi-purified by afhnity column chroma- 
tography from culture supernatants of Cos 7 cells transfected with 
the IL-5 cDNA clone, was kindly provided by Dr.  R. Coffman 
(DNAX, Palo Alto, CA). It was usually tested at 15 ng/ml. IL-7 
(provided by Dr. F. Lee, DNAX) was used as a 5% dilution (,~15 
U/ml) of a culture supematant  of Cos 7 cells transfected with the 
human IL-7 cDNA done. TGF-31 (R and D Systems Inc., Min- 
neapolis, MN) was usually tested at 0.6 ng/ml, except where indi- 
cated. The EBV-encoded protein BCRF1/viral  Ibl0 (rib10) and 
human Ibl0 (hlbl0) were used as culture supernatants of Cos 7 
cells transfected with the vIL-10 or hIL-10 cDNA clones. In some 
experiments, highly purified Escherichia  coli-derived rvlbl0 (5  x 
10  s U/mg) (kindly provided by Dr.  R. Kastelein, DNAX) was 
used at a concentration  of 500 ng/ml. 
Isolation of slgD § and slgD-  B  Cell Populat~ns.  Tonsillar  mono- 
nuclear cells were separated by standard Ficoll/I-Iypaque gradient 
method and were next submitted to E rosetting with SRBC. Non- 
rosetting  ceils (E-  fraction) were labded with anti-T  cell (anti- 
CD2 and anti-CD3  mAbs) and antimonocyte  (anti-CD14  mAb) 
mAbs,  and  subsequently  incubated  twice with magnetic  beads 
coated with anti-mouse IgG antibodies (Dynal, Oslo, Norway). 
Residual non-B cells were removed by applying a magnetic field 
for 10 rain.  The purity of the B cell populations  obtained after 
this procedure was greater than 95% as estimated by FACScan  | 
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CD2, CD3, and CD14 mAbs. Isolation of sIgD + and slgD-  B 
cell populations was performed using a preparative magnetic cell 
separation system (MACS|  Becton-Dickinson  & Co.) according 
to the experimental procedure described in detail by Miltenyi et 
al. (25). Briefly, unfractionated  tonsil B cells resuspended in PBS 
plus 1% BSA plus 0.01% sodium azide plus 5 mM EDTA, were 
labded by sequential incubation with biotinylated goat anti-human 
IgD antibodies (Amersham International)  and FITC-conjugated 
streptavidin (Immunotech, Luminy, France). After washings in PBS 
plus sodium azide plus EDTA, B cells were resuspended at 2  x 
108 cells/ml in the same buffer and incubated with super paramag- 
netic beads (5 #1 of the solution  provided by the manufacturers 
for 108 cells) conjugated  to biotin. Cells were next deposited on 
specially designed columns and separated into positive and nega- 
tive populations  using a high-gradient  magnetic field. Unlabeled 
sIgD- B cells were duted from the column while the magnetic 
field was applied and slgD + B cells labeled with magnetic beads 
were next recovered by vigorous washing  of the column matrix 
after its removal from the magnet. Purity of both populations was 
directly assessed by fluorescence analysis on a FACScan  |  since the 
positive cells were stained by the complex biotin-anti-IgD/FITC- 
streptavidin/biotin-magnetic  beads. 
B Cell Cultures.  All cultures were performed in Iscove's  medium 
enriched with 50 #g/ml human  transferrin,  5 #g/ml bovine in- 
sulin, 0.5% BSA, 5  x  10 -5 M2-/3 MF. (all from Sigma Chemical 
Co., St. Louis, MO) and 5% heat-inactivated FCS (Flow Labora- 
tories, Irvine, CA). All B cell cultures were performed in presence 
of irradiated  (7,000 rad) CDw32/FcTKII-transfected Ltk-  cells 
(CDw32 L cells), kindly provided by Dr. K. Moore (DNAX), ac- 
cording  to the experimental procedure described previously (15, 
16). In most experiments, B cells were seeded in round-bottomed 
microtiter trays at a density of 5  x  104 cells per well under a final 
volume of 200 t~l, for a culture period of 10 d. Cytokines,  poly- 
clonal B cell activators (SAC, insolubilized  anti-IgM  antibodies, 
and the anti-CD40 mAb 89), and irradiated CDw32 L cells (5  x 
10Uwell) were added at the onset of the culture. IgM, IgG, IgA, 
and IgE levels were measured in culture supematants by standard 
ELISA techniques as described elsewhere (26, 27). Each culture 
point was performed  in quadruplicate. 
Limiting Dilution Cultures and Analysis.  For limiting  dilution 
experiments,  slgD + B ceils were seeded in 96-well V-shaped mi- 
crotiter  trays at  decreasing cell concentrations  (0.3--6.7  x  103 
cells/weU) under a final volume  of 150/zl,  in enriched  Iscove's 
medium as described above. For the lowest cell numbers (0.3-243 
cells/well), a total of 80 replicate cultures was set up for each cell 
density. For the highest cell densities (0.73-6.7  x  103 cells/well), 
each culture point was set up as 40 replicates. 5  x  108 irradiated 
CDw32 L cells were dispensed in each culture well. Four different 
culture conditions were applied to sIgD + B cells in limiting  dilu- 
tion experiments: (a) SAC plus anti-CD40 mAb, (b) SAC plus anti- 
CD40 m.Ab plus vIL-10 (2.5%), (c) SAC plus anti-CD40 mAb plus 
TGF-fl (0.6 ng/ml), (d) SAC plus anti-CD40 mAb plus vIbl0 plus 
TGF-fl. Cultures were individually assayed for their IgA content 
by ELISA after a culture period of 12 d. Wells in which the OD 
value was at least four times higher than background  levels were 
considered positive. Calculations to determine the frequency of IgA- 
secreting cells were carried out according to Taswell (28). The fre- 
quency of negative responses at each input number of B cells was 
used to construct a plot of the log10 of the number of negative 
cultures versus the number of cultured  B cells. The frequency of 
B cells able to secrete IgA was calculated from the 37% intercept 
of the regression line, according to the Poisson distribution.  The 
goodness of fit of the regression line was tested using the X  z test. 
In all experiments performed,  the results obtained were compat- 
ible with the hypothesis of a single hit event, suggesting that we 
were dealing with a single ceU type dilution. 
Results 
slgD §  B  Cells Display  the Phenotypic Features of Mantle 
Zone B  Cells.  The  phenotype  of the  sIgD +  and  sIgD- 
populations recovered after magnetic separation was exam- 
ined using mAbs directed against surface molecules sdectivdy 
distributed on mantle zone B cells, such as slgM (29), CD23 
(30), and UCL 3D3 (23), or on germinal center B ceils, such 
as CD10 or CD38 (31). Expression of other antigens,  such 
as CD20 and CD44, which have been reported to display 
different  staining  intensities  in mantle  zone and  germinal 
centers (31, 32), was also assessed on both B cell fractions. 
As shown in Fig. 1, the fluorescence peak obtained with slgD 
in the positive population was monotonal and dearly sepa- 
rated  from  the  control,  indicating  the  virtual  absence of 
sIgD-  B  call contaminants  in the positive fraction.  Con- 
versely, slgD + B cells were consistently undetectable in the 
negative popuhtion even after 48 h of culture (data not shown), 
therefore excluding underestimation  of sIgD + 13 ceil con- 
ruminants possibly due to internalization of sIgD as a conse- 
quence of the isolation procedure.  All slgD + B cells were 
homogeneously positive for slgM,  CD23,  UCL 3D3,  and 
CD44 expression, weakly stained with the anti-CD38 mAb, 
and lacked CD10.  In contrast,  slgD-  B cells did not bind 
the anti-CD23 and UCL 3D3 antibodies and weakly expressed 
sIgM as estimated by the low percentages of positive ceils 
(17  +_  8%, mean  +  SD of three experiments)  and by the 
low intensity of staining. CD10 and CD38 were distributed 
on 50 _+  10% and 36  _+  10% (mean  +_ SD of three experi- 
ments)  of the sIgD-  B ceils,  respectively. CD20 was uni- 
formly expressed on all sIgD + B ceils, but the levels of ex- 
pression of this antigen differentiated three subsets within 
the  sIgD-  compartment:  a minor  negative population,  a 
dimly stained population, and a brightly stained population. 
Similarly, three intensities of expression of CD44 were ob- 
served on sIgD-  B calls,  thus dividing  this population  in 
CD44 hish, CD44  l~  and  CD44-  subsets.  Taken  together, 
these results indicate that B calls positively selected on the 
basis of slgD expression are phenotypically related to mantle 
zone B ceils,  whereas sIgD-  B cells constitute a heteroge- 
neous population including a subset of cells displaying some 
of the distinctive phenotypic features of geiu~inal center B cells. 
T  Cell-independent Differentiation of B cells after Dual Liga- 
tion ofslgs and CD40.  Functional assays were performed to 
determine  the  capacity  of slgD +  and  slgD-  B  cells  to 
differentiate in vitro, after ligation of surface Igs, CD40, or 
both.  For this purpose, 5  x  104 purified B cells from each 
population were seeded in wells of microtiter trays together 
with 5  x  103 irradiated CDw32 L cells and submitted to 
the following conditions of stimulation: anti-IgM antibodies, 
SAC, anti-CD40  mAb 89,  anti-IgM  antibodies plus mAb 
89, and SAC plus mAb 89. IgM, IgG, IgA, and IgE levels 
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Figure  1.  Immunofluorescence 
analysis of slgD + and slgD- B cell 
populations.  Horizontal axes iUus- 
trate log of fluorescence and vertical 
axes indicate relative cell numbers. 
The fluorescence  histograms shown 
are representative of three experi- 
ments.  Each  staining profile (solid 
lines) was superimposed with that 
of the negative control (dotted lines) 
performed with an isotype-matched 
unrelated mAb. 
were measured in 10-d culture supernatants  by ELISA. As 
illustrated in Table 1, neither anti-Ig reagents nor crosslinked 
anti-CD40 mAb could stimulate  Ig synthesis from sIgD + 
B cells. However, when sIgs and CD40 were simultaneously 
crosslinked  (SAC plus  anti-CD40  or anti-IgM plus  anti- 
CD40), sIgD + B cells were induced to secrete high amounts 
of Igs. The levels of Igs secreted by sIgD + after costimula- 
tion with SAC and crosslinked anti-CD40 antibodies reached, 
on average, 40 times the amount of Igs produced in response 
to each of those B cell stimulants  used alone (as estimated 
in 10 separate experiments).  The Ig response of sIgD + B 
ceils under these culture conditions was exclusively  restricted 
to the IgM isotype. However, the levels of IgM secreted by 
sIgD §  B  cells in  response  to  SAC and anti-CD40  were 
10-20-fold higher than those induced by the combination 
of anti-IgM and anti-CD40 antibodies. Similarly, in the ab- 
sence of exogenous factors, slgD- B cells were induced for 
Ig synthesis when sIgs and CD40 were concomitantly trig- 
gered by SAC and anti-CD40 mAb (Table 2). However, the 
pattern of Ig isotypes produced by slgD- B cells in this ac- 
tivation system was strikingly different from that of sIgD + 
B cells, since  both IgM and IgG were secreted  in large amounts. 
IgG was reproducibly found to be the major isotype induced 
and constituted on average  76 _+ 11% of the overall  Ig produc- 
tion (mean + SD of seven experiments) in these experimental 
conditions.  IgA secretion varied from one tonsil sample to 
674  Ibl0 and TGF-B Induce slgD + B Cells to Synthesize IgA Table  1.  Stimultaneous Crosslinking of slgs and CD40 Induces lgM Production from slgD § B  Cells 
Anti CD40 mAb  Anti-Ig reagents  IgM  IgG  IgA  IgE 
ltg/ml  /zg/ml  ltg/ml  pg/ml 
-  -  -*  0.04  _+  0.005  0.03  _+  0.007  -1 
-  Anti-IgM  -  0.05  _+  0.004  0.04  _+  0.006  - 
-  SAC  -  0.05  _+  0.005  0.03  +_  0.002  - 
+  -  0.2  _+  0.09  0.05  _+  0.004  0.03  _+  0.007  - 
+  Anti-IgM  1.8  _+  0.2  0.07  _+  0.01  0.04  +_  0.002  - 
+  SAC  29  _+  1.6  0.1  _+  0.05  0.07  _+  0.02  - 
5  x  104 slgD §  B cells were co-cultured for 10 d  with 5  x  103 irradiated CDw32  L cells in complete medium, with anti-Ig reagents (SAC or 
insolubilized anti-IgM antibodies) with the anti-CD40 mAb 89, or with combinations of anti-Ig reagents and anti-CD40 mAb. Ig levels represent 
the mean  _+  SD values  of quadruplicate determinations. Representative of seven experiments. 
* <0.08/~g/ml. 
<150 pg/ml. 
Table  2.  Stimulatenous  Crosslinking of slgs and CD40 Induces IgM Production  from slgD-  B Cells 
Anti CD40 mAb  Anti-Ig reagent  IgM  IgG  IgA  IgE 
/zg/ml  Itg/ml  lzg/ml  pg/ml 
-  -  0.1  _+  0.04  0.1  _+  0.09  0.04  _+  0.003  -* 
-  Anti-IgM  -*  0.1  _+  0.02  0.06  __.  0.009  - 
-  SAC  0.1  _+  0.01  0.05  _+  0.01  0.05  _+ 0.01  - 
+  -  0.3  _+  0.02  0.3  _+  0.08  0.1  _+  0.03  - 
+  Anti-IgM  0.2  _+  0.03  0.2  _+  0.04  0.4  _+ 0.004  - 
+  SAC  4.9  _+ 0.1  7.2  _+  0.7  0.09  _+  0.001  - 
Same culture conditions as in Table 1.  Ig levels represent the mean  •  SD of quadruplicate 
* <0.08  #g/ml. 
<150 pg/ml. 
determinations. Representative of seven experiments. 
another but usually remained a minor component of the Ig 
response elicited by SAC and anti-CD40 from slgD- B cells. 
IgE levels always remained below the threshold of detection 
whatever the cell population examined. In contrast to slgD + 
B cells, slgD- B cells produced minor amounts of Igs upon 
costimulation with anti-IgM and anti-CD40 antibodies,  a 
result consistent with the low expression of slgM on this 
population. 
Activated slgD + and slgD-  B Cells Produce Large Amounts 
of lgs in Response to I1.,10.  We next examined the capacity 
of various cytokines to modulate the Ig response dicited by 
SAC and anti-CD40 from sIgD + and sIgD-  B  cells.  Sev- 
eral recombinant factors including Ibl-7,  TNF-c~, TGF-/~ 
and  IFN-3' repeatedly failed to enhance Ig  synthesis from 
sIgD + B cells, activated through concomitant triggering of 
surface Igs and CD40 antigen (data not shown). In contrast, 
human and viral I1:10 dramatically increased the IgM produc- 
tion elicited by the combination of SAC and mAb 89 from 
slgD + B cells  (Table 3 and Fig.  2, top). IgG and IgA were 
also produced, but they remained a minor component of the 
Ig response stimulated by Ibl0 from slgD + B cells since the 
levels of production of these isotypes constituted, on average, 
1.4  _+  0.7%  and 0.5  _+  0.2%  (mean  +  SD of 10 experi- 
ments) of the overall Ig synthesis,  respectively.  I1:10 also syn- 
ergized with SAC and crosslinked anti-CD40 to stimulate 
IgM,  IgG, and IgA production from slgD-  B cells  (Table 
3 and Fig. 2, bottom). In contrast to slgD + B cells, IgG was 
the predominant isotype secreted by slgD-  B  cells  in re- 
sponse to I1:10 since it accounted, on average, for 68  _+  13% 
(mean  _+  SD of 10 experiments) of the overall Ig synthesis, 
whereas IgM and IgA accounted for 19.5  +  15% and 12.5 
_+  12%, respectively. IgE synthesis was not enhanced above 
background levels (150 pg/ml) by I1:10 whatever the B cell 
population considered. The stimulatory effects of I1:10 on 
IgM,  IgG,  and  IgA  synthesis  on both  populations  were 
confirmed with purified recombinant material (Table 4), in- 
dicating that the enhancing effect of I1:10  on Ig synthesis 
is an innate property of the molecule. I1:10 failed to stimu- 
675  Defrance et al. Table  3.  Human  IL-IO Enhances Ig Synthesis from  Activated slgD § and slgD-  B  Cells 
B cell  Culture  IgM  IgG  IgA 
/zg/ml 
0  -*  0.08  _+  0.03  0:06  _+  0.003 
sIgD +  SAC  +  anti-CD40  1.6  _+  0.2  0.1  +  0.03  0.06  _+  0.01 
SAC  +  anti-CD40 
+  hIL-10  172  +  17  4.2  _+  0.9  0.4  _+  0.1 
0  -  0.1  _+  0.03  0.07  _+  0.01 
slgD-  SAC  +  anti-CD40  0.2  _+  0.07  1.2  +  0.4  0.1  +_  0.04 
SAC  +  anti-CD40 
+  hlL-10  8.2  _+ 0.7  26.5  +  2  10  +  1.6 
5  x  104 slgD + or slgD-  B cells were cultured for 12 d with complete medium or costimulated with SAC and the anti-CD40 mAb 89 presented 
on CDw32 L cells  in absence  or presence  of Cos-7-derived human IL-10  used at 10%.  Ig levels represent  the mean  _+  SD values of quadruplicate 
determinations. 
* <0.08 #g/ml. 
late  Ig  secretion  over  background  levels  when  added  to 
slgD + or slgD-  B cells in the absence of stimulatory agents 
(data not shown). 
TGF-[3 Specifically Enhances IgA Synthesis from slgD § B 
Cells while Inhibiting  that of slgD-  B Cells.  Since  TGF-3 
had been demonstrated to induce LPS-activated mouse B cells 
to switch to IgA synthesis (3,  33),  we tested its ability to 
influence IgA  secretion from slgD + and  slgD-  B  cells in 
the various culture conditions described above. As illustrated 
in Fig. 3 (top), TGF-3 strongly potentiated the IgA synthesis 
induced by vlIA0 from slgD + B cells,  but suppressed both 
IgM and IgG production elicited by vlIA0 in this cell popu- 
lation. The stimulator),  effect of TGF-3 on IgA secretion was 
obtained within a narrow concentration range (0.5-2 ng/ml). 
Above 2 ng/ml, TGF-3 gradually lost its IgA-enhancing  effect 
(data not shown). The IgA levels reached in this particular 
culture system with optimal doses of TGF-fl were generally 
10-30 times higher than those obtained with vIL-10 alone. 
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Figure 2.  Dose-response curves 
of the vlbl0 induced IgM, IgG, and 
IgA  synthesis  from  slgD +  and 
slgD-  B cells. 5  x  104 slgD + B 
cells (top) or slgD- B cells (bottom) 
were co-cuhured for 10 d in round- 
bottomed  microtiter  trays  with 
SAC,  the  anti-CD40  mAb  89 
presented  on CDw32 L cells, and 
serial dilutions of  Cos-7-derived vlL- 
10. Ig levels are expressed in #g/ml 
and represent the mean  _+ SD values 
of  quadruplicate  determinations. 
Representative  of seven experiments. 
676  IL-10 and TGF-3 Induce slgD + B Cells  to Synthesize IgA Table  4.  Purified vlL-10 Enhances Ig Synthesis from Activated slgD + and slgD-  B Cells 
B cell  Culture  IgM  IgG  IgA 
~g/ml 
0  0.09  +  0.02  0.08  +  0.007  0.04  +  0.003 
slgD +  SAC  +  anti-CD40  4.2  _+  0.03  0.1  _+  0.02  0.05  _+  0.01 
SAC  +  anti-CD40 
+  vlL-10  235  +  13  3.7  +  0.09  0.4  _+  0.08 
0  -*  0.6  +  0.06  0.07  _+  0.03 
slgD-  SAC  +  anti-CD40  0.1  _+  0.02  2.5  +_  0.8  0.1  +_  0.02 
SAC  +  anti-CD40 
+  vlL-10  7.9  +  0.5  142  +  9.6  8.7  _+  0.2 
Same culture conditions as in Table 3. Ig levels represent the mean +  SD of quadruplicate determinations. Purified viral IL-10 was used at 500 ng/ml. 
* <  0.08/~g/ml. 
It is striking that the IgA-enhancing capacity of TGF-fl ap- 
peared to be strictly  restricted to the slgD + compartment, 
since the rib10  induced IgM,  IgG,  and IgA synthesis in 
slgD-  B  cells  (Fig.  3,  bottom) were inhibited in a dose- 
dependent manner by TGF-13. Fig. 3 shows that IgA secre- 
tion by slgD-  B cells is blocked by concentrations of TGF-3 
that are stimulatory for IgA production by slgD + B cells. 
As illustrated by Fig. 4, TGF-fl was found to specifically en- 
hance IgA synthesis from slgD + B cells costimulated with 
SAC, anti-CD40, and human IL-10, therefore indicating that 
the IgA-potentiating activity of TGF-3 is equally detected 
in the presence of the viral or human forms of ILl0.  The 
IgA response of unfractionated  B cells to II~10 was blocked 
by TGF-~ (data not shown). 
TGF-~ Increases the Frequency of slgD + B  Cells Driven to 
IgA Synthesis by vlIAO.  Limiting dilution experiments were 
next performed to determine whether IgA synthesis induced 
by TGF-fl and vlL-10 in sIgD + B cells resulted from an in- 
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Figure 3.  Effect of combinations 
of vlL-10 and TGF-fl on the pattern 
of Ig isotypes  secreted  by slgD + 
and  slgD-  B  cells.  5  x  104 
purified  slgD +  B  cells  (top)  or 
slgD- B cells (bottom), co-cultured 
with 5  x  103 irradiated CDw32 L 
cells,  were  stimulated  with SAC, 
anti-CD40, and a fixed dilution of 
Cos-7-derived vlL-10 (5%), in the 
absence or presence of three concen- 
trations  of TGF-fl (0.6,  1.25,  and 
2.5 ng/ml). IgM, IgG, and IgA syn- 
thesis was measured after a culture 
period of 10 d. Ig levels are expressed 
in/~g/ml and represent the mean _+ 
SD values of quadruplicate determi- 
nations. Representative of five ex- 
periments. 120' 
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Figure 4.  Effect of combinations  of hlir  and TGF-B on the pattern 
of Ig isotypes produced  by slgD + B cells. 5  x  104 slgD + B cells co- 
cultured with 5  x  103 irradiated  CDw32 L calls, were stimulated  with 
SAC, anti-CD40, and a fixed concentration of Cos-7-derived human Ib 
10 (5 %) in the absence or presence of serial dilutions of TGF-3. IgG, IgA, 
and IgM levels were measured after a culture period of 10 d and are ex- 
pressed in/zg/ml. The results represent the mean _+ SD values of quadru- 
plicate determinations.  Representative  of two separate experiments. 
creased frequency of IgA-secreting clones or from the expan- 
sion and maturation of a few IgA committed precursors con- 
taminating the slgD + populations. Therefore, slgD + B cells 
were  cultured  at  various  cell  densities  (0.3-6.7  x  103 
cells/well)  with  a  fixed number (5  x  103) of irradiated 
CDw32 L cells in V-shaped microtiter trays, for a period of 
12 d under different conditions of stimulation.  As shown in 
Fig. 5, virtually no IgA-producing cell could be detected in 
cultures stimulated by SAC plus anti-CD40 or by SAC plus 
anti-CD40  plus  TGF-3.  Costimulation of slgD §  B cells 
with SAC, anti-CD40 mAb, and vlL-10 resulted in the emer- 
gence of IgA-secreting cells with a frequency of 1/340  for 
the representative experiment depicted in Fig. 5. Addition 
of TGF-3 to the latter culture condition increased the fre- 
quency of sIgD + B ceils recruited to secrete IgA up to 1/75. 
No IgA-bearing cell could be detected by flow cytometry  anal- 
ysis in  the  starting  sIgD+AIgM  +  populations  (data  not 
shown). Therefore, the present results suggest that TGF-3 
used in combination with vlL-10 enhances IgA synthesis from 
slgD + B cells by increasing the frequency of IgA-produdng 
clones. 
Ligation of CD40 is Sufficient to Allow slgD + B Cells to Pro- 
duce IgA in Response to vlLlO and TGFB  We next attempted 
to determine the minimal activation signal required for in- 
duction of IgA synthesis from sIgD + B cells. As illustrated 
by Fig. 6, ligation of slgs by insolubilized anti-IgM antibodies 
or SAC did not allow sIgD + B cells to secrete IgA in re- 
sponse to either rib10 or the combination of rill0  and 
TGF-3. This was not due to a lack of responsiveness of B 
cells to vIL-10 in this assay system, since rib10 significantly 
enhanced IgM synthesis from SAC-activated sIgD + B cells 
(3.9  +_ 0.6/~g/ml vs. 0.3  _+ 0.05/~g/ml in control cuhures, 
for the experiment depicted in Fig. 6).  Conversely, slgD + 
B ceils were induced for IgA secretion in response to rill0 
and rill0  +  TGF-B after crosslinking  of CD40 by mAb 
89, presented on CDw32 L cells. The stimulatory effect of 
TGF-3 on IgA synthesis was augmented when sIgD + B 
cells were simultaneously activated by anti-Ig reagents and 
crosslinked anti-CD40 antibodies. Taken together, these results 
indicate that induction of IgA synthesis from sIgD + B cells 
in response to vIL-10 and vlL,10 plus TGF-B requires an acti- 
vation signal delivered by ligation of CD40, but not by cross- 
linking of slgs. 
Discussion 
Naive B cells that coexpress sIgM and sIgD migrate from 
the bone marrow to the periphery and form the primary fol- 
licles in secondary lymphoid organs. After antigen stimula- 
tion, primary follicles develop into secondary follicles sche- 
matically composed of two major microanatomical structures: 
the mantle zone in which slgM+/slgD + naive B ceUs are 
located,  and  the  germinal center in  which  the  antigen- 
dependent maturation process occurs (34). Here, we have at- 
tempted to isolate naive B cells by the means of anti-IgD 
antibodies to build up a reliable  experimental model that could 
be used to study the cytokine regulation of isotype switching 
to IgG and IgA. This technical approach was supported by 
the fact that IgG- and IgA-committed precursors reside within 
the sIgD- B cell subset (35, 36). The results of the pheno- 
typic  and  functional  analysis  of  sIgD +  B  calls both 
confirmed that our separation criteria allowed isolation  of 
naive B cells. First, sIgD + B cells homogeneously expressed 
a panel of markers identifying mantle zone B cells and virtu- 
ally lacked expression of CD10 and CD38, which are dis- 
tributed on certain germinal center B calls. Second, sIgD + 
B  cells costimulated  with  SAC  and  an  anti-CD40  mAb 
presented on CDw32 L cells displayed a pattern of isotype 
secretion exclusively restricted to IgM. The heterogeneity  of 
the sIgD-  B cell subset,  suggested by the complex distri- 
bution of CD10, CD20, and CD44, could reflect the diver- 
678  IL-10 and TGF-~ Induce  slgD + B Cells to Synthesize  lgA Figure 5.  Frequency of slgD + B cells recruited  to 
produce IgA in response to rib10 or vlL-10 + TGF-/3 
as  determined  by  limiting  dilutions  experiments. 
Decreasing concentrations  of slgD + B cells were cul- 
tured for 12 d in the presence of 5  x  103 irradiated 
CDw32 L cells and  stimulated  with: SAC  +  anti- 
CD40, SAC + anti-CD40  + TGF-/3  (0.6 rig/m1), SAC 
+  anti-CD40  + vIL-10  (2.5%), or SAC + anti-CD40 
+  vlL-10 +  TGF-/~. The results are expressed by plot- 
ting the percentage of IgA-negative weUs against the 
number of B cells seeded in the culture.  Shaded areas 
represent the 95% confidence limits of the regression 
lines calculated from the experimental  points.  Repre- 
sentative  of two separate experiments. 
sity of the stages of B cell maturation (centrocytes versus 
centroblasts, for instance) found within the germinal center. 
Yet, considering that a few slgD- B cells also lacked CD20 
(Fig.  1), expression of which is lost at the plasma cell stage 
(37), it is probable that a minor population of extra-follicular 
B cells, such as plasmablasts,  is also included within this B 
cell compartment. 
Ligation of slgs and CD40 can promote B cell prolifera- 
tion in combination  with other stimuli (38, 39), or can directly 
induce entry of B cells into cycle when the anti-Ig (40) or 
Figure 6.  IgA response  of sIgD + B cells to vIL-10 and vlL-10  + 
TGF-B after activation with Ig-crosslinking  agents or with an immobi- 
lized anti-CD40 mAb.  5  x  104  slgD + B cells were stimulated with 
TGF-/3 (0.6 ng/ml), vlL-10 (5%), or vIL-10 +  TGF-/3 in the presence 
of insolubilized anti-IgM antibodies, SAC, anti-CD40,  SAC +  anti-CD40, 
or anti-lgM antibodies  +  anti-CD40.  Irradiated  CDw32 L cells (5  x 
103/well) were added to each culture point. IgA levels (#g/m1) were de- 
termined after a culture period of 10 d. They are expressed as mean  _+ 
SD values of quadruplicate  determinations.  Representative  of three sepa- 
rate  experiments. 
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anti-CD40 antibodies (15) are presented under an immobi- 
lized form. However, our data indicate that T cell-indepen- 
dent maturation of human B cells can be achieved, in the 
absence  of exogenous factors,  by  the  combination of Ig- 
crosslinking agents and immobilized anti-CD40 antibodies. 
In this respect,  this particular mode of activation of human 
B cells presents some homology with the LPS-induced stim- 
ulation of murine B cells. The apparent lack of exogenous 
factor requirement for Ig synthesis, in this activation system, 
could be due to the endogenous  production of B call differen- 
tiation factors by the irradiated CDw32 L cell transfectants 
and/or by the B cells themselves.  In any case, the absence 
of secretion of Igs using downstream heavy chain genes by 
slgD +  B  cells  in  these  culture  conditions indicates  that 
simultaneous triggering of CD40 and sIgs is not sufficient 
to induce Ig isotype switching. Additionally, it is noteworthy 
that SAC was consistently more potent than anti-IgM anti- 
bodies for stimulation of B call differentiation when com- 
bined with the anti-CD40 mAb. In the slgD-  subset, anti- 
IgM antibodies failed to cooperate with anti-CD40 for Ig 
synthesis in spite of the presence  of sIgM § B cells which 
were inducible for IgM secretion by the combination of SAC 
and anti-CD40.  One plausible explanation for this finding 
could be that the stimulatory effect of SAC resides in its 
capacity to trigger both slgs and MHC dass II molecules 
since Staphylococcal exotoxins have been described to stimu- 
late B cell differentiation through binding to MHC class II 
antigens (41). 
In  our  hands,  sIgD +  B  cells  could  secrete  moderate 
amounts of IgA upon costimulation with an anti-CD40 mAb 
presented on CDw32 L cells and Ibl0. The frequency of IgA- 
secreting cells (<0.5%, on average) induced by Ibl0 is com- 
patible with a level of contamination of sIgD § B cells with 
IgA-committed precursors  which  would  fall  beyond  the 
threshold of detection of the flow-cytometry analysis. There- 
fore, considering that human and viral IL-10 are extremely 
potent B cell growth and differentiation factors (42), we cannot rule out the possibility that a minor contaminating popula- 
tion ofpostswitch B cells could account for the IL-10-medi- 
ated IgA synthesis by slgD + B cells. However,  one of the 
major points which emerged from the present study was the 
observation that TGF-fl could stimulate IgA secretion from 
naive human B lymphocytes. Two lines of evidence argue in 
favor of the hypothesis that IgA isotype switching occurs 
in response to TGF-fl stimulation. First, it is well documented 
that TGF-fl inhibits both proliferation (43) and differentia- 
tion (44) of human B lymphocytes. Therefore, it is unlikely 
that its IgA-potentiating effect could result from outgrowth 
and maturation of a few slgA § contaminants. Second, in ac- 
cordance with data previously reported in routine models (33), 
we observed that TGF-fl strongly suppressed IgA synthesis 
in the slgD- B cell subset thus excluding the possibility that 
IgA-committed precursors could constitute the target of the 
IgA-stimulatory effect of TGF-fl observed in the slgD + B 
cell population. In light of these findings, one could recon- 
sider the effects of I1.-10 on IgA synthesis by slgD + B cells. 
Indeed, under the extreme conditions of stimulation provided 
by the combination of SAC, anti-CD40, CDw32 L cells, and 
IL-10, B cells might be induced for endogenous cytokine re- 
lease. Since it has been demonstrated that human B cells can 
produce TGF-fl upon SAC stimulation (43), the IL,10-induced 
IgA secretion observed in slgD + B cells might be indirectly 
mediated by B cell-derived TGF-fl. 
In conclusion, we have developed an in vitro system, relying 
on the concomitant ligation of slgs and CD40, which allows 
T-independent differentiation of human B  cells. This ex- 
perimental model has permitted us to show that TGF-fl can 
stimulate IgA production from naive B cells, probably as a 
consequence of class switching. Our data indicate that cross- 
linking of CD40, but not of slgs, provides one of the obliga- 
tory  signals  required  for  induction of IgA  synthesis by 
slgD + B cells in response to TGF-fl. The TGF-fl-dependent 
regulation of IgA isotype selection in humans appears to differ 
from the IL-4-dependent regulation of IgE dass switching. 
Indeed, whereas anti-CD40 antibodies and Ib4 are sufficient 
to induce commitment of human B cells to IgE secretion, 
combinations of anti-CD40 and TGF-fl consistently failed 
to elicit  IgA synthesis from slgD + B cells. Therefore, we 
speculate that (a) IgA isotype switching occurs after costimu- 
lation of slgD + B cells with anti-CD40 and TGF-fl; and (b) 
the signal necessary for growth and differentiation of the newly 
IgA-committed B cells is lacking under these culture condi- 
tions, unless  IIr  is also provided. The notion that II.,10 
could be involved in the final B cell maturation step is sup- 
ported by the observation that Ibl0 can drive human B lym- 
phocytes to a plasma-like stage of differentiation (F. Rousset 
et al., unpublished observations).  Experiments are presently 
being carried  out to test the validity of such a model. 
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